Further studies in different populations are needed in the direction for concluding as this study indicates that TLR2 and TLR9 polymorphism may impact only the clinical symptoms of psoriasis but not their pathogenic role in psoriasis development (Zabłotna et al., 2017[228]). The gene discussed is TLR9; the disease is psoriasis.